Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

被引:12
作者
Burns, Madeleine D. [1 ]
Boribong, Brittany P. [1 ]
Bartsch, Yannic C. [2 ]
Loiselle, Maggie [1 ]
St Denis, Kerri J. [2 ]
Sheehan, Maegan L. [2 ]
Chen, Jessica W. [2 ]
Davis, Jameson P. [1 ]
Lima, Rosiane [1 ]
Edlow, Andrea G. [3 ]
Fasano, Alessio [1 ]
Balazs, Alejandro B. [2 ]
Alter, Galit [2 ]
Yonker, Lael M. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Boston, MA 02114 USA
[2] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[3] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Vincent Ctr Reprod Biol, Boston, MA 02114 USA
关键词
SARS-CoV-2; COVID-19; pediatrics; adolescents; vaccines; boosters; immunology; antibodies; STATES;
D O I
10.3390/vaccines10040492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls for broader understanding of the adolescent immune profile after mRNA vaccination. We tested the durability and cross-reactivity of anti-SARS-CoV-2 serologic responses over a six-month time course in vaccinated adolescents against the SARS-CoV-2 D614G ("wild type") and Omicron antigens. Serum from 77 adolescents showed that anti-Spike antibodies wane significantly over six months. After completion of a two-vaccine series, cross-reactivity against Omicron-specific receptor-binding domain (RBD) was seen. Functional humoral activation against wild type and Omicron SARS-CoV-2 also declines over time in vaccinated adolescent children. Evidence of waning mRNA-induced vaccine immunity underscores vulnerabilities in long-term pediatric protection against SARS-CoV-2 infection, while cross-reactivity highlights the additional benefits of vaccination. Characterization of adolescent immune signatures post-vaccination will inform guidance on vaccine platforms and timelines, and ultimately optimize immunoprotection of children.
引用
收藏
页数:11
相关论文
共 17 条
[1]   Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants [J].
Accorsi, Emma K. ;
Britton, Amadea ;
Fleming-Dutra, Katherine E. ;
Smith, Zachary R. ;
Shang, Nong ;
Derado, Gordana ;
Miller, Joseph ;
Schrag, Stephanie J. ;
Verani, Jennifer R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07) :639-651
[2]   A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples [J].
Ackerman, Margaret E. ;
Moldt, Brian ;
Wyatt, Richard T. ;
Dugast, Anne-Sophie ;
McAndrew, Elizabeth ;
Tsoukas, Stephen ;
Jost, Stephanie ;
Berger, Christoph T. ;
Sciaranghella, Gaia ;
Liu, Qingquan ;
Irvine, Darrell J. ;
Burton, Dennis R. ;
Alter, Galit .
JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 366 (1-2) :8-19
[3]   Humoral signatures of protective and pathological SARS-CoV-2 infection in children [J].
Bartsch, Yannic C. ;
Wang, Chuangqi ;
Zohar, Tomer ;
Fischinger, Stephanie ;
Atyeo, Caroline ;
Burke, John S. ;
Kang, Jaewon ;
Edlow, Andrea G. ;
Fasano, Alessio ;
Baden, Lindsey R. ;
Nilles, Eric J. ;
Woolley, Ann E. ;
Karlson, Elizabeth W. ;
Hopke, Alex R. ;
Irimia, Daniel ;
Fischer, Eric S. ;
Ryan, Edward T. ;
Charles, Richelle C. ;
Julg, Boris D. ;
Lauffenburger, Douglas A. ;
Yonker, Lael M. ;
Alter, Galit .
NATURE MEDICINE, 2021, 27 (03) :454-+
[4]   Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination [J].
Canaday, David H. ;
Oyebanji, Oladayo A. ;
Keresztesy, Debbie ;
Payne, Michael ;
Wilk, Dennis ;
Carias, Lenore ;
Aung, Htin ;
St Denis, Kerri ;
Lam, Evan C. ;
Rowley, Christopher F. ;
Berry, Sarah D. ;
Cameron, Cheryl M. ;
Cameron, Mark J. ;
Wilson, Brigid M. ;
Balazs, Alejandro B. ;
King, Christopher L. ;
Gravenstein, Stefan .
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) :E884-E887
[5]   Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron [J].
Carreno, Juan Manuel ;
Alshammary, Hala ;
Tcheou, Johnstone ;
Singh, Gagandeep ;
Raskin, Ariel J. ;
Kawabata, Hisaaki ;
Sominsky, Levy A. ;
Clark, Jordan J. ;
Adelsberg, Daniel C. ;
Bielak, Dominika A. ;
Gonzalez-Reiche, Ana Silvia ;
Dambrauskas, Nicholas ;
Vigdorovich, Vladimir ;
Srivastava, Komal ;
Sather, D. Noah ;
Sordillo, Emilia Mia ;
Bajic, Goran ;
van Bakel, Harm ;
Simon, Viviana ;
Krammer, Florian .
NATURE, 2022, 602 (7898) :682-+
[6]   A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation [J].
Fischinger, Stephanie ;
Fallon, Jonathan K. ;
Michell, Ashlin R. ;
Broge, Thomas ;
Suscovich, Todd J. ;
Streeck, Hendrik ;
Alter, Galit .
JOURNAL OF IMMUNOLOGICAL METHODS, 2019, 473
[7]  
Fowlkes AL, 2022, MMWR-MORBID MORTAL W, V71, P422, DOI [10.1101/2021.12.10.21267408v3, 10.15585/mmwr.mm7111e1]
[8]   Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents [J].
Frenck, Robert W., Jr. ;
Klein, Nicola P. ;
Kitchin, Nicholas ;
Gurtman, Alejandra ;
Absalon, Judith ;
Lockhart, Stephen ;
Perez, John L. ;
Walter, Emmanuel B. ;
Senders, Shelly ;
Bailey, Ruth ;
Swanson, Kena A. ;
Ma, Hua ;
Xu, Xia ;
Koury, Kenneth ;
Kalina, Warren V. ;
Cooper, David ;
Jennings, Timothy ;
Brandon, Donald M. ;
Thomas, Stephen J. ;
Tureci, Ozlem ;
Tresnan, Dina B. ;
Mather, Susan ;
Dormitzer, Philip R. ;
Sahin, Ugur ;
Jansen, Kathrin U. ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03) :239-250
[9]  
Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006, 10.1101/2021.02.14.21251704]
[10]   A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis [J].
Karsten, Christina B. ;
Mehta, Nickita ;
Shin, Sally A. ;
Diefenbach, Thomas J. ;
Slein, Matthew D. ;
Karpinski, Wiktor ;
Irvine, Edward B. ;
Broge, Thomas ;
Suscovich, Todd J. ;
Alter, Galit .
JOURNAL OF IMMUNOLOGICAL METHODS, 2019, 471 :46-56